CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 2 Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01379625
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:38.229823+00:00
Published At: 2017-03-23T00:00:00+00:00
Record Updated At: 2017-03-23
Results Posted At: 2017-03-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency", "Carnitine Palmitoyltransferase 2 (CPT2) Deficiency", "Mitochondrial Trifunctional Protein (TFP) Deficiency", "Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-03-23"
protocolSection.identificationModule.nctId: "NCT01379625"
protocolSection.identificationModule.officialTitle: "Phase 2 Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorders"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-03-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.